George E. Wright
Papers
2
Total Citations
38
H-Index
2
About
George E. Wright is a biophysical pharmacologist whose research centers on the molecular mechanisms of multidrug resistance, particularly the role of ATP-binding cassette (ABC) transporters like P-glycoprotein (P-gp). His major contributions lie in developing innovative in vitro systems to study drug-transporter interactions, enabling more accurate prediction of how compounds inhibit or modulate these efflux pumps. In his highly cited 2012 work (31 citations), Wright established a reconstituted P-gp liposomal system alongside LLC-MDR1 cell monolayers, providing a robust platform for evaluating P-gp–drug interactions that directly informs drug development and toxicity screening. He further advanced this methodology in 2015 by creating a liposomal assay for H+-coupled multidrug transporters, expanding the toolkit for studying proton-dependent resistance mechanisms. Wright’s work bridges fundamental transport biology and applied pharmacology, offering researchers practical, reproducible models to assess candidate drugs for transporter-mediated liabilities. His achievements include pioneering these liposome-based approaches that reduce reliance on complex cell-based systems, making transporter inhibition studies more accessible and high-throughput. For students and researchers in drug discovery and cancer pharmacology, Wright’s methods remain essential for understanding and overcoming multidrug resistance.
Research Focus
Key Achievements
Top Papers
- 1
- 2